Tonghua Dongbao's announcement on the clinical approval of GLP-1 and GIP dual-target receptor agonists (THDBH120 for injection) for weight loss
Tonghua Dongbao's announcement on the company's participation in the national centralized drug procurement (insulin special continuation) to be selected
Tonghua Dongbao Announces Implementation Notice on the 2020 Equity Incentive Restricted Stock Repurchase and Cancellation
Legal opinion of Beijing Zhonglun Law Firm on Tonghua Dongbao terminating the implementation of the 2020 Stock Options and Restricted Stock Incentive Plan and the 2020 Incentive Share Repurchase and Cancellation
Announcement of resolutions of Tonghua Dongbao's 2023 Annual General Meeting of Shareholders
Legal Opinion of Tonghua Dongbao's 2023 Annual General Meeting of Shareholders
Tonghua Dongbao's 2023 Annual General Meeting of Shareholders Meeting Materials
Tonghua Dongbao's indicative announcement on the 2020 Equity Incentive Plan Stock Option Restrictions Enforcement Period
Tonghua Dongbao Announces Release of Controlling Shareholder Shares
Tonghua Dongbao Announces Self-Enforcement Results and Stock Changes for the First Quarter of 2024 of the 2020 Equity Incentive Plan
Tonghua Dongbao's announcement on the release and re-pledge of the controlling shareholder's shares
Tonghua Dongbao's announcement on the resignation of the chairman and election of the new chairman, vice chairman, and the convener of the 11th Board Strategy Committee
Tonghua Dongbao 2023 Annual Report Summary
Tonghua Dongbao 2023 Annual Report
2023 Tonghua Dongbao Financial Statement Audit Report
Special report on Tonghua Dongbao's summary table of non-operating capital occupation and other related capital transactions in 2023
Tonghua Dongbao 2023 Independent Director Debriefing Report (Bi Yan)
Tonghua Dongbao 2023 Internal Control Evaluation Report
Tonghua Dongbao 2023 Sustainability Report
Verification Report on the Deposit and Use of Funds Raised by Tonghua Dongbao in 2023
No Data